Bluefin Capital Management’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-30,000
Closed -$2K 947
2021
Q3
$2K Buy
+30,000
New +$851K ﹤0.01% 714
2020
Q2
Sell
-100,000
Closed -$25K 397
2020
Q1
$25K Buy
+100,000
New +$2.41M ﹤0.01% 350
2018
Q1
Sell
-488,000
Closed -$1.09M 424
2017
Q4
$1.09M Hold
488,000
0.07% 159
2017
Q3
$2.51M Sell
488,000
-37,300
-7% -$564K 0.3% 63
2017
Q2
$2.48M Buy
525,300
+13,100
+3% +$157K 0.27% 81
2017
Q1
$4.31M Sell
512,200
-331,700
-39% -$4.56M 0.56% 32
2016
Q4
$9.54M Buy
843,900
+106,200
+14% +$1.95M 0.59% 19
2016
Q3
$5.5M Sell
737,700
-1,002,600
-58% -$25.9M 0.2% 29
2016
Q2
$11.7M Buy
1,740,300
+307,500
+21% +$8.71M 1.16% 16
2016
Q1
$14.4M Buy
1,432,800
+937,300
+189% +$69.3M 1.44% 15
2015
Q4
$18.4M Buy
+495,500
New +$55.7M 1.47% 9
2015
Q3
Sell
-68,700
Closed -$1.93M 490
2015
Q2
$1.93M Buy
+68,700
New +$15.2M 0.12% 147
2015
Q1
Sell
-520,600
Closed -$869K 436
2014
Q4
$869K Sell
520,600
-229,600
-31% -$30.9M 0.05% 277
2014
Q3
$2.81M Buy
750,200
+745,748
+16,751% +$88.9M 0.15% 148
2014
Q2
$3.4M Buy
+4,452
New +$568K 0.15% 119

Other funds holding BHC

Bluefin Capital Management's BHC Position: Q2 2020 in Review

Bluefin Capital Management sold out of Bausch Health (BHC) in Q2 2020, closing a stake of 23,290 shares — an estimated $361K sold.

Bluefin Capital Management first reported a position in BHC in Q3 2014 and held it in 11 quarters. The position peaked at $26M in Q3 2015. 303 funds tracked by Wall St. Rank hold BHC as of Q2 2020.

  • Bluefin Capital Management reported no remaining Bausch Health position as of Q2 2020 after selling out during the quarter.
  • Bluefin Capital Management sold 23,290 Bausch Health shares in Q2 2020, an estimated $361K.
  • Bluefin Capital Management first reported a position in Bausch Health in Q3 2014 and held it in 11 quarters.
  • Bluefin Capital Management's Bausch Health position peaked at $26M in Q3 2015.
  • 303 funds tracked by Wall St. Rank held Bausch Health as of Q2 2020.

Based on Bluefin Capital Management's 13F filing for Q2 2020, filed 17 Aug 2020.